Imuvac®

Imuvac® is an inactivated trivalent vaccine launched in 2006.

Constituents

Imuvac® contains the appropriate quantities of A and B virus strains recommended by the World Health Organization. These strains vary from year to year and therefore vaccines from previous years may not contain the current recommended virus strains.

The constituents of Imuvac® for the 2018/2019 season, as recommended by the World Health Organization, are as follows:

  • Active constituents

    Influenza virus surface antigens (haemagglutinin and neuraminidase) of the following strains (propagated in fertilised hens’ eggs from healthy chicken flocks) per 0.5 ml dose:

    • A/Michigan/45/2015 (H1N1)pdm09-like strain (A/Singapore/GP1908/2015, IVR-180) – 15 micrograms haemagglutinin
    • A/Singapore/INFIMH-16-0019/2016 (H3N2)-like strain (A/Singapore/INFIMH-16-0019/2016, NIB-104) – 15 micrograms haemagglutinin
    • B/Colorado/06/2017-like strain (B/Victoria/2/87 lineage) (B/Maryland/15/2016, NYMC BX-69A) – 15 micrograms haemagglutinin
  • Other constituents

    • Potassium dihydrogen phosphate
    • Disodium phosphate dihydrate
    • Sodium chloride
    • Potassium chloride
    • Calcium chloride dihydrate
    • Magnesium chloride hexahydrate
    • Water for injections
    • Residue or traces of:
      • Formaldehyde
      • Cetyltrimethylammonium bromide
      • Ovalbumin
      • Chicken proteins
      • Polysorbate 80
      • Gentamicin

Contraindications

  • Allergy to eggs or chicken protein
  • Patients hypersensitive (allergic) to eggs or chicken protein should not be vaccinated with Imuvac®.
  • Allergy to gentamicin or any other constituent of the vaccine. As Imuvac® may contain minimal amounts of gentamicin, they should not be used in patients hypersensitive to this antibiotic.
  • Patients who are allergic to any of the ingredients or to any of the components that could be present in trace amounts, should not receive Imuvac® Please also see Constituents.
  • Vaccination should be postponed in patients with febrile illness or acute infection.

Packaging

Packaging solutions to meet storage demands means that Imuvac® is conveniently packaged in slim, ten-tray blister-free packs with tamper proof seals.

Siliconised needle designed
for injection comfort

The 0.25ml dose for children
<36 months of age is clearly marked

16mm needle length

Pre-filled to deliver the
exact 0.5ml dose

More information on Influvac sub-unit


More information on Influvac sub-unit Tetra

The website you are trying to access is designed for healthcare professionals, the content is not designed for the general public.

Are you a healthcare professional?

YES
NO